599 related articles for article (PubMed ID: 943556)
1. Determination of adhesive properties of variant metastatic melanoma cells to BALB/3T3 cells and their virus-transformed derivatives by a monolayer attachment assay.
Winkelhake JL; Nicolson GL
J Natl Cancer Inst; 1976 Feb; 56(2):285-91. PubMed ID: 943556
[TBL] [Abstract][Full Text] [Related]
2. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
Nicolson GL; Fidler IJ; Poste G
J Natl Cancer Inst; 1986 Mar; 76(3):511-9. PubMed ID: 3456465
[TBL] [Abstract][Full Text] [Related]
3. The selection and characterization of an invasive variant of the B16 melanoma.
Hart IR
Am J Pathol; 1979 Dec; 97(3):587-600. PubMed ID: 507192
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
Fidler IJ; Nicolson GL
Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
[TBL] [Abstract][Full Text] [Related]
5. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
Fidler IJ; Nicolson GL
J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
[TBL] [Abstract][Full Text] [Related]
6. Adhesive properties of weakly and highly metastatic melanoma cell lines.
Urushihara H; Ikawa Y; Tsuruo T
Gan; 1984 Jun; 75(6):534-9. PubMed ID: 6088347
[TBL] [Abstract][Full Text] [Related]
7. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
Nicolson GL; Dulski K; Basson C; Welch DR
Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
[TBL] [Abstract][Full Text] [Related]
8. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.
Hart IR; Raz A; Fidler IJ
J Natl Cancer Inst; 1980 Apr; 64(4):891-900. PubMed ID: 6929000
[TBL] [Abstract][Full Text] [Related]
10. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
Irimura T; Gonzalez R; Nicolson GL
Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
[TBL] [Abstract][Full Text] [Related]
11. The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties.
Irimura T; Nicolson GL
J Supramol Struct Cell Biochem; 1981; 17(4):325-36. PubMed ID: 7328676
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence probes in metastatic B16 melanoma membranes.
Schroeder F
Biochim Biophys Acta; 1984 Oct; 776(2):299-312. PubMed ID: 6477911
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
15. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures.
Passaniti A; Hart GW
J Biol Chem; 1988 Jun; 263(16):7591-603. PubMed ID: 3372501
[TBL] [Abstract][Full Text] [Related]
16. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
Nabi IR; Raz A
Cancer Res; 1988 Mar; 48(5):1258-64. PubMed ID: 3342405
[TBL] [Abstract][Full Text] [Related]
17. Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation.
Lotan R; Raz A
Cancer Res; 1983 May; 43(5):2088-93. PubMed ID: 6187442
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential.
Updyke TV; Nicolson GL
Clin Exp Metastasis; 1986; 4(4):273-84. PubMed ID: 3791726
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
[TBL] [Abstract][Full Text] [Related]
20. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]